D-0619-2020 Class III Terminated
FDA drug recall D-0619-2020 was initiated by Glenmark Pharmaceuticals Inc., USA on Nov 15, 2019 and is designated Class III. Reason for recall: Defective delivery system; product is not foaming or is coming out as liquid. The recall status is terminated (terminated Mar 15, 2024). Affected quantity: a) 480 packs; b) 240 packs.
Recall details
- Product Type
- Drugs
- Report Date
- Dec 18, 2019
- Initiation Date
- Nov 15, 2019
- Termination Date
- Mar 15, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- a) 480 packs; b) 240 packs
Product description
Clobetasol Propionate Foam (Emulsion Formulation), 0.05% a) 50 g pack (NDC 68462-625-27) and b) 100 g pack (NDC 68462-625-94), Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited Plot No. B-25, MIDC, Shendra Aurangabad, Maharashtra -431210, India Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430
Reason for recall
Defective delivery system; product is not foaming or is coming out as liquid.
Distribution pattern
Nationwide
Code information
Lot 14190067, exp Jul-2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0619-2020
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026